awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q33605194-6BDB63E7-8E38-4318-9695-A5CD3719293B
Q33605194-6BDB63E7-8E38-4318-9695-A5CD3719293B
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33605194-6BDB63E7-8E38-4318-9695-A5CD3719293B
Comparison of FOLFIRI with or without cetuximab in patients with resected stage III colon cancer; NCCTG (Alliance) intergroup trial N0147.
P2860
Q33605194-6BDB63E7-8E38-4318-9695-A5CD3719293B
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33605194-6BDB63E7-8E38-4318-9695-A5CD3719293B
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
0005f6afe56e5f303be37c76e9697051671e92ac
P2860
Association of KRAS p.G13D mutation with outcome in patients with chemotherapy-refractory metastatic colorectal cancer treated with cetuximab.